marks published for opposition - U.S. Patent and Trademark Office

MAY 1, 2012 U.S. PATENT AND TRADEMARK OFFICE TM 1443
THE MARK CONSISTS OF THREE STYLIZED CURVED
TRIANGLES SURROUNDING A CENTRAL POINT, EACH
WITH A CONCAVE INNER SURFACE; ONE OF THE
TRIANGLES IS BLUE, ONE GREEN, AND ONE TEAL.
CLASS 16—PAPER GOODS AND PRINTED
MATTER
FOR PRINTED REPORTS AND PRINTED VISUALS,
NAMELY, INFORMATION GRAPHICS PROVIDING
STATEWIDE, MARKET AREA, PAYER, HOSPITAL,
AND PHYSICIAN MEASUREMENTS ON OUTCOMES,
QUALITY, MORTALITY, INFECTIONS, COMPLICA-
TIONS, UTILIZATION, AND PRICE FOR USE BY
THIRD PARTY PAYERS, HOSPITALS, PHYSICIANS,
HEALTHCARE ORGANIZATIONS, INSURANCE COM-
PANIES, HMOS, EMPLOYERS, LEGAL COUNSEL, THE
MEDIA, GOVERNMENT ENTITIES AND CONSUMERS
(U.S. CLS. 2, 5, 22, 23, 29, 37, 38 AND 50).
FIRST USE 7-31-2008; IN COMMERCE 7-31-2008.
CLASS 35—ADVERTISING AND BUSINESS
FOR CONSULTING SERVICES RELATED TO MEDI-
CAL COST MANAGEMENT; MANAGEMENT SERVICES
OF A BUSINESS NATURE FOR CLINICAL TRIALS IN
THE FIELD OF INVESTIGATIONAL DRUGS; DATA
COMPILATION AND ANALYSIS IN THE FIELD OF
HEALTHCARE MANAGEMENT, NAMELY, CONDUCT-
ING PHARMACOECONOMICS, HEALTH ECONOMICS
AND STATISTICAL RESEARCH FOR BUSINESS PUR-
POSES; COMPUTERIZED DATABASE MANAGEMENT
AND DATA PROCESSING SERVICES IN THE FIELDS
OF HEALTHCARE, PHARMACEUTICALS, PHARMACO-
GENOMIC, BIOTECHNICAL, AND MEDICAL PRO-
DUCTS AND DEVICES; COMPUTERIZED DATABASE
MANAGEMENT AND DATA PROCESSING SERVICES
IN THE FIELDS OF HEALTHCARE, PHARMACEUTI-
CALS, PHARMACOGENOMIC, BIOTECHNICAL, AND
MEDICAL PRODUCTS AND DEVICES; BUSINESS CON-
SULTING SERVICES IN THE FIELDS OF HEALTH-
CARE, PHARMACEUTICALS, PHARMACOGENOMIC,
BIOTECHNICAL, AND MEDICAL PRODUCTS AND
DEVICES; SUPPLY CHAIN MANAGEMENT, NAMELY,
TRACKING AND MANAGEMENT OF CLINICAL TRIAL
SUPPLIES AND RESEARCH MATERIALS USED IN
SUCH; PROVIDING STATISTICAL INFORMATION
AND ANALYSIS VIA COMPUTER FOR USE WITH
CLINICAL TRIAL DATA FOR BUSINESS PURPOSES;
BUSINESS CONSULTATION SERVICES FOR THE
HEALTHCARE INDUSTRY; BUSINESS CONSULTING
IN THE FIELD OF CLINICAL AND HEALTH ECONOM-
IC RESEARCH SERVICES FOR HEALTHCARE COMPA-
NIES; PREPARING STATISTICAL BUSINESS REPORTS
RESULTING FROM CLINICAL TRIALS AND LABORA-
TORY DATA ANALYSIS; CONSULTATION IN THE
FIELD OF PATIENT RECRUITMENT; DATA PREPARA-
TION FOR BUSINESS PURPOSES, NAMELY, PREPARA-
TION OF MEDICAL AND SCIENTIFIC DATA FOR USE
BY INSURANCE COMPANIES AND THIRD PARTY
MEDICAL REIMBURSEMENT ORGANIZATIONS (U.S.
CLS. 100, 101 AND 102).
FIRST USE 7-31-2008; IN COMMERCE 7-31-2008.
CLASS 42—SCIENTIFIC AND COMPUTER
SERVICES
FOR MEDICAL AND SCIENTIFIC RESEARCH, DATA
COLLECTION AND ANALYSIS IN THE NATURE OF
CLINICAL RESEARCH AND CONDUCTING CLINICAL
TRIALS IN THE FIELDS OF HEALTHCARE, MEDICAL
CARE AND PHARMACEUTICALS; SCIENTIFIC RE-
SEARCH IN THE FIELD OF GENERAL HEALTH AND
MEDICAL AND SCIENTIFIC RESEARCH, NAMELY,
CONDUCTING CLINICAL TRIALS BY PROVIDING
CLINICAL INDICATORS CALCULATED USING MEDI-
CAL CLAIMS DATA THAT ARE USED TO MEASURE
QUALITY OF MEDICAL CARE; COMPILATION AND
ANALYSIS IN THE FIELD OF SCIENTIFIC AND MED-
ICAL RESEARCH, NAMELY, CONDUCTING PHARMA-
COECONOMICS, HEALTH ECONOMICS, MEDICAL
LABORATORY DATA ANALYSIS, AND STATISTICAL
MEDICAL RESEARCH; PHARMACEUTICAL DEVELOP-
MENT SERVICES IN THE FIELDS OF MOLECULAR
MEDICINE; HEALTHCARE, NAMELY, SCIENTIFIC RE-
SEARCH CONSULTING FOR IMPROVED CLINICAL
TRIAL DESIGN; MEDICAL RESEARCH THAT ANA-
LYZES DATA TO IDENTIFY PATTERNS ACROSS PA-
TIENT GROUPS OR DISEASE PROGRESSION;
PHARMACEUTICAL DEVELOPMENT, NAMELY, DE-
SIGN, RESEARCH AND DEVELOPMENT OF DRUGS,
PHARMACEUTICALS AND MEDICINES FOR OTHERS;
CLINICAL DEVELOPMENT SERVICES FOR OTHERS,
NAMELY, RESEARCH AND CONSULTATION IN THE
FIELDS OF PHARMACEUTICAL DRUG DEVELOP-
MENT AND CLINICAL TRIAL DESIGN; MEDICAL
LABORATORY DATA ANALYSIS, CLINICAL DIAGNO-
SIS RESEARCH AND DIAGNOSTIC TESTING RE-
SEARCH; PREPARATION OF REPORTS AND
RESEARCH CONCERNING DEVELOPMENT OF MEDI-
CINES, PHARMACEUTICALS, GENETICS, BIOLOGY,
BIOTECHNOLOGY AND PHARMACEUTICAL DRUGS;
CONSULTING SERVICES IN THE FIELDS OF PHAR-
MACEUTICALS RESEARCH, AND BIOTECHNOLOGY
FIELDS; PROVIDING AN ON-LINE DATABASE IN THE
FIELD OF MEDICAL, PHARMACEUTICAL, AND BIO-
TECHNICAL RESEARCH AND ANALYSIS; MANAGE-
MENT SERVICES OF A SCIENTIFIC AND TECHNICAL
NATURE FOR CLINICAL TRIALS IN THE FIELD OF
INVESTIGATIONAL DRUGS, NAMELY, CONDUCTING
CLINICAL PROTOCOLS AND TRIALS FOR OTHERS;
CONSULTING SERVICES REGARDING SCIENTIFIC
ASPECTS OF CLINICAL TRIALS OF INVESTIGA-
TIONAL DRUGS, NAMELY, ADVISING OTHERS ON
CONDUCTING CLINICAL PROTOCOLS AND TRIALS;
TECHNICAL WRITING FOR OTHERS OF CLINICAL
TRIAL REPORTS; RESEARCH AND CONSULTATION
IN THE CLINICAL MEDICAL FIELD, NAMELY, RE-
SEARCH AND ANALYSIS PROVIDED TO HEALTH-
CARE PROVIDERS, SUPPLIERS OF MEDICAL
DEVICES AND PHARMACEUTICAL PRODUCTS, AND
SUPPLIERS OF MEDICAL SOFTWARE AND MEDICAL
INFORMATION MANAGEMENT SERVICES; MEDICAL
QUALITY EVALUATION SERVICES, NAMELY, PRO-
VIDING DATA COLLECTION, ANALYSIS, AND RE-
PORTING SERVICES FOR PATIENT DATA, CLINICAL
INFORMATION, TREATMENT OPTIONS AND TREAT-
MENT SUCCESS FOR THE MEDICAL INDUSTRY;
PROVIDING AN ON-LINE COMPUTER DATABASE IN
THE FIELD OF HEALTHCARE, NAMELY, HEALTH
AND PRODUCTIVITY RESEARCH AND ANALYSIS;
ASSESSMENT SURVEYS FOR HEALTH AND MEDICAL
PURPOSES, NAMELY, IN RESEARCH CONCERNING
MEDICINES, PHARMACEUTICALS, GENETICS, BIOL-
OGY, BIOTECHNOLOGY AND DRUGS; QUALITY EVA-
LUATION SERVICES, NAMELY, SURVEYING
PATIENTS TO ASSESS QUALITY OF LIFE, BURDEN
OF DISEASE AND OVERALL SATISFACTION WITH
ACCESS TO MEDICAL CARE TO DETERMINE SERVICE
QUALITY FOR THE MEDICAL INDUSTRY (U.S. CLS.
100 AND 101).
FIRST USE 7-31-2008; IN COMMERCE 7-31-2008.
CLASS 44—MEDICAL, BEAUTY AND AGRI-
CULTURAL SERVICES
FOR CONSULTATION IN THE FIELD OF DRUG USE
TESTING SERVICES; CONSULTATION IN THE FIELD
OF HEALTHCARE; PROVIDING PHARMACEUTICAL
ADVICE; PROVIDING AN INTERACTIVE ON-LINE
COMPUTER DATABASE IN THE FIELD OF MEDICAL
DIAGNOSTICS (U.S. CLS. 100 AND 101).
FIRST USE 7-31-2008; IN COMMERCE 7-31-2008.
CLASS 45—PERSONAL AND LEGAL SER-
VICES
FOR CONSULTING SERVICES IN THE FIELD OF
RESEARCH AND ANALYSIS OF DRUG PRESCRIPTION
AND ASSOCIATED DATA, NAMELY, REGULATORY
COMPLIANCE CONSULTING AS IT APPLIES TO PRE-
SCRIPTIONDRUGSAMPLING(U.S.CLS.100AND101).
FIRST USE 7-31-2008; IN COMMERCE 7-31-2008.